Top Story
Merck Initiates Phase III Study of Breast Cancer Vaccine
PharmaAsia, 7/1/2009
Merck has announced the initiation of its global Phase III clinical study of the therapeutic cancer vaccine Stimuvax (BLP25 liposome vaccine, L-BLP25) in patients with advanced, inoperable breast cancer.
The STRIDEa ...
PharmaAsia, 7/1/2009
Merck has announced the initiation of its global Phase III clinical study of the therapeutic cancer vaccine Stimuvax (BLP25 liposome vaccine, L-BLP25) in patients with advanced, inoperable breast cancer.
The STRIDEa ...
[Full story | More stories]
Recent stories- USP Signs Agreements with Chinese Drug Control Authorities
- GSK and Shenzhen Neptunus to Develop Vaccines in China
- Health Leaders Convene in Korea to Save Women's Lives
- Astrazeneca and Merck Collaborate to Investigate Anticancer Regimen
- Sanofi Pasteur Lands US$190 Million Order from the US Government
Latest News
VBI Researchers Develop Method for Breast Cancer Biomarker Discovery
PharmaAsia, 7/3/2009
Biocon and Mylan Collaborate to Enter Global Generic Biologics Market
PharmaAsia, 7/3/2009
GVK Biosciences Announces Agreement with University of Tokyo on GPCR Database
PharmaAsia, 7/2/2009
Gentronix and Apredica to Create Predictive-Toxicology Service
PharmaAsia, 7/2/2009
Astrazeneca: Pozen Submits NDA For Pn400
PharmaAsia, 7/1/2009
Reproducible Cell Migration Screening Assay
PharmaAsia, 6/30/2009
Discovery of Cell Water Gate May Lead to New Cancer Drugs
PharmaAsia, 6/30/2009
PharmaAsia, 7/3/2009
Biocon and Mylan Collaborate to Enter Global Generic Biologics Market
PharmaAsia, 7/3/2009
GVK Biosciences Announces Agreement with University of Tokyo on GPCR Database
PharmaAsia, 7/2/2009
Gentronix and Apredica to Create Predictive-Toxicology Service
PharmaAsia, 7/2/2009
Astrazeneca: Pozen Submits NDA For Pn400
PharmaAsia, 7/1/2009
Reproducible Cell Migration Screening Assay
PharmaAsia, 6/30/2009
Discovery of Cell Water Gate May Lead to New Cancer Drugs
PharmaAsia, 6/30/2009
Science
VBI Researchers Develop Method for Breast Cancer Biomarker Discovery
PharmaAsia, 7/3/2009 Understanding Asthma for New Treatment Potential
PharmaAsia, 6/29/2009 Cytopia Cancer Program Reaches Milestone
PharmaAsia, 6/15/2009 Richter-Helm BioLogics: Breakthrough in Purification of Antibody Fragments
PharmaAsia, 6/8/2009 Sigma-Aldrich Introduces Kinases for High-Throughput Screening
PharmaAsia, 5/28/2009
PharmaAsia, 7/3/2009 Understanding Asthma for New Treatment Potential
PharmaAsia, 6/29/2009 Cytopia Cancer Program Reaches Milestone
PharmaAsia, 6/15/2009 Richter-Helm BioLogics: Breakthrough in Purification of Antibody Fragments
PharmaAsia, 6/8/2009 Sigma-Aldrich Introduces Kinases for High-Throughput Screening
PharmaAsia, 5/28/2009
Business
Biocon and Mylan Collaborate to Enter Global Generic Biologics Market
PharmaAsia, 7/3/2009 GVK Biosciences Announces Agreement with University of Tokyo on GPCR Database
PharmaAsia, 7/2/2009 Gentronix and Apredica to Create Predictive-Toxicology Service
PharmaAsia, 7/2/2009 Astrazeneca: Pozen Submits NDA For Pn400
PharmaAsia, 7/1/2009 China Pharma Holdings: SFDA Approval for Clinical Trials
PharmaAsia, 6/29/2009
PharmaAsia, 7/3/2009 GVK Biosciences Announces Agreement with University of Tokyo on GPCR Database
PharmaAsia, 7/2/2009 Gentronix and Apredica to Create Predictive-Toxicology Service
PharmaAsia, 7/2/2009 Astrazeneca: Pozen Submits NDA For Pn400
PharmaAsia, 7/1/2009 China Pharma Holdings: SFDA Approval for Clinical Trials
PharmaAsia, 6/29/2009
New Products
Reproducible Cell Migration Screening Assay
PharmaAsia, 6/30/2009 Applied Biosystems Introduces Real-time PCR Solution
PharmaAsia, 6/19/2009 Concentration of Protein from a Single Drop
PharmaAsia, 6/16/2009 Esco Launches Perchloric Acid Laboratory Fume Hood
PharmaAsia, 6/15/2009 Qiagen Launches Product to Replace Invasive Procedures
PharmaAsia, 6/9/2009
PharmaAsia, 6/30/2009 Applied Biosystems Introduces Real-time PCR Solution
PharmaAsia, 6/19/2009 Concentration of Protein from a Single Drop
PharmaAsia, 6/16/2009 Esco Launches Perchloric Acid Laboratory Fume Hood
PharmaAsia, 6/15/2009 Qiagen Launches Product to Replace Invasive Procedures
PharmaAsia, 6/9/2009
[More]
Cover Stories
API Manufacturing: Complying with International GMP Regulations
PharmaAsia, 6/1/2009 Cell-Based Assays: Advancing Discovery
PharmaAsia, 5/1/2009 Pharmacogenomics: Bringing Hope
PharmaAsia, 3/1/2009 Establishing the Standards in Biomarkers Research
PharmaAsia, 1/1/2009 Robust Standards in Proteomic Research
PharmaAsia, 11/1/2008
PharmaAsia, 6/1/2009 Cell-Based Assays: Advancing Discovery
PharmaAsia, 5/1/2009 Pharmacogenomics: Bringing Hope
PharmaAsia, 3/1/2009 Establishing the Standards in Biomarkers Research
PharmaAsia, 1/1/2009 Robust Standards in Proteomic Research
PharmaAsia, 11/1/2008
[More]
Current Issue
Cover StoryAPI Manufacturing: Complying with International GMP Regulations
PharmaAsia, 6/1/2009
The majority of medicinal products manufactured in Europe and the US contain Active Pharmaceutical Ingredients (APIs) and excipients which have been manufactured in Asia. In recent years, these active and inactive pharmaceutical ingredients have become increasingly available globally as trading goods. ...
API Manufacturing: Product Safety
PharmaAsia, 6/1/2009 Talent Acquisition in Emerging Markets: More than Just the Money (Part Two)
PharmaAsia, 6/1/2009 Editor''s Note
Taking Center Stage
PharmaAsia, 6/1/2009







